HK1099689A1 - Combination of a heterocyclic compound and an antioxidant and use thereof for the manufacture of a medicament for treating obesity - Google Patents

Combination of a heterocyclic compound and an antioxidant and use thereof for the manufacture of a medicament for treating obesity

Info

Publication number
HK1099689A1
HK1099689A1 HK07106254.1A HK07106254A HK1099689A1 HK 1099689 A1 HK1099689 A1 HK 1099689A1 HK 07106254 A HK07106254 A HK 07106254A HK 1099689 A1 HK1099689 A1 HK 1099689A1
Authority
HK
Hong Kong
Prior art keywords
antioxidant
medicament
manufacture
combination
heterocyclic compound
Prior art date
Application number
HK07106254.1A
Other languages
English (en)
Inventor
Louis Casteilla
Luc Penicaud
Pascal Berthelot
Catherine Dacquet
Daniel-Henri Caignard
Original Assignee
Servier Lab
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab, Centre Nat Rech Scient filed Critical Servier Lab
Publication of HK1099689A1 publication Critical patent/HK1099689A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK07106254.1A 2004-03-31 2007-06-12 Combination of a heterocyclic compound and an antioxidant and use thereof for the manufacture of a medicament for treating obesity HK1099689A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0403359A FR2868313B1 (fr) 2004-03-31 2004-03-31 Nouvelle association entre un compose heterocyclique et un agent antioxydant et les compositions pharmaceutiques qui les contiennent
PCT/FR2005/000755 WO2005099694A1 (fr) 2004-03-31 2005-03-30 Association entre un compose heterocyclique et un agent antioxydant et son utilisation pour le traitement de l’obesite

Publications (1)

Publication Number Publication Date
HK1099689A1 true HK1099689A1 (en) 2008-10-24

Family

ID=34945535

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07106254.1A HK1099689A1 (en) 2004-03-31 2007-06-12 Combination of a heterocyclic compound and an antioxidant and use thereof for the manufacture of a medicament for treating obesity

Country Status (19)

Country Link
US (1) US20070167502A1 (es)
EP (1) EP1729767A1 (es)
JP (1) JP2007530643A (es)
KR (1) KR100842567B1 (es)
CN (1) CN100536842C (es)
AR (1) AR048355A1 (es)
AU (1) AU2005232420B8 (es)
BR (1) BRPI0509389A (es)
CA (1) CA2563104A1 (es)
EA (1) EA012966B1 (es)
FR (1) FR2868313B1 (es)
GE (1) GEP20094637B (es)
HK (1) HK1099689A1 (es)
MA (1) MA28467B1 (es)
MY (1) MY142039A (es)
NO (1) NO20064858L (es)
UA (1) UA86801C2 (es)
WO (1) WO2005099694A1 (es)
ZA (1) ZA200607798B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2894965B1 (fr) * 2005-12-20 2008-01-25 Servier Lab Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2898125B1 (fr) * 2006-03-06 2008-06-13 Servier Lab Nouveaux derives heterocycliques cycloalkyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5832794A (en) * 1993-01-06 1994-08-15 T.S. Consult Aps Medium comprising a pharmacological/biological active substance
JP2001527551A (ja) * 1997-05-01 2001-12-25 ブリストル−マイヤーズ・スクイブ・カンパニー Ｍｔｐインヒビターと脂溶性ビタミンの組合せおよび該組合せを用いる血清脂質レベルの降下法
US6020383A (en) * 1999-01-11 2000-02-01 Eastman Chemicals Company Method for reducing blood cholesterol and/or blood triglycerides
FR2804431A1 (fr) * 2000-02-02 2001-08-03 Adir Nouveaux derives heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE10044805A1 (de) * 2000-09-11 2002-04-04 Martin Klingenberg Verwendung von Coenzym Q zur Regulierung der Funktion der Entkopplerproteine
BR0114701A (pt) * 2000-10-26 2003-11-18 Fournier Lab Ireland Ltd Combinação de fenofibrato e coenzima q 10 para tratamento de disfunção endotelial
JP2003116487A (ja) * 2001-10-15 2003-04-22 Beverly Corporation:Kk 痩身用食品
FR2845601B1 (fr) * 2002-10-11 2005-07-08 Servier Lab Nouvelle association entre un compose heterocyclique et un agent antioxydant et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
JP2007530643A (ja) 2007-11-01
NO20064858L (no) 2006-10-25
FR2868313A1 (fr) 2005-10-07
AU2005232420B2 (en) 2009-02-19
KR20060133073A (ko) 2006-12-22
EP1729767A1 (fr) 2006-12-13
MY142039A (en) 2010-08-30
EA012966B1 (ru) 2010-02-26
KR100842567B1 (ko) 2008-07-01
AU2005232420A1 (en) 2005-10-27
US20070167502A1 (en) 2007-07-19
MA28467B1 (fr) 2007-03-01
CN100536842C (zh) 2009-09-09
CA2563104A1 (fr) 2005-10-27
AR048355A1 (es) 2006-04-19
FR2868313B1 (fr) 2008-08-15
WO2005099694A8 (fr) 2006-11-09
ZA200607798B (en) 2008-05-28
WO2005099694A1 (fr) 2005-10-27
CN1938024A (zh) 2007-03-28
EA200601632A1 (ru) 2007-04-27
UA86801C2 (ru) 2009-05-25
GEP20094637B (en) 2009-03-10
AU2005232420B8 (en) 2009-06-11
BRPI0509389A (pt) 2007-09-18

Similar Documents

Publication Publication Date Title
EP1812078A4 (en) KINASE INHIBITORS FOR THE TREATMENT OF DIABETES AND OBESITY
EP1991218A4 (en) USE OF CYCLOLIGNANS IN THE TREATMENT OF TYPE 2 DIABETES AND AS CONTRACEPTIVES
ZA200703601B (en) Medicaments for the treatment or prevention of fibriotic diseases
PT2463283E (pt) Compostos heterocíclicos de fenil amido condensados para a prevenção e tratamento de doenças mediadas pela glucoquinase
EP1720863A4 (en) HETEROARYLAMINOPYRAZOLE DERIVATIVES FOR TREATING DIABETES
HK1186125A1 (en) Quinoline derivatives for the treatment of latent tuberculosis
PL382308A1 (pl) Związki heterocykliczne i sposoby stosowania
EP1771188A4 (en) METHOD AND COMPOSITIONS FOR TREATING ADIPOSITAS, INSULINED DISEASES AND HYPERCHOLESTERINEMIA
EP1985302A4 (en) DRUGS FOR TUMOR THERAPY AND ITS USE
EP1749532A4 (en) MEDICAMENT FOR HEALING OR TREATMENT OF INJURY
ZA200702380B (en) Substituted heterocyclic compounds and uses thereof
PL1811866T3 (pl) Zastosowanie związków przeciwutleniających przy uszkodzeniach mięśni
EP1833990A4 (en) MARKERS FOR DIAGNOSING AML, B-ALL AND T-ALL
PL1740204T3 (pl) Lecznicze zastosowanie alfa-mannozydazy
ZA200708033B (en) Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia
EP1750698A4 (en) 5-ANILINO-4-HETEROARYLPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES
EP1810689A4 (en) MEANS FOR THE PREVENTION AND / OR TREATMENT OF DIABETES
IL179670A0 (en) Heterocyclic compounds and processes for the preparation thereof
EP1852432A4 (en) NITROGENIC HETEROCYCLIC COMPOUND AND THEIR MEDICAL USE
EP1726313A4 (en) MEDICAMENT FOR THE PREVENTION AND TREATMENT OF ARTERIOSCLEROSIS
EP1757282A4 (en) USE OF KAURANE COMPOUNDS IN THE MANUFACTURE OF MEDICAMENTS
EP2005964A4 (en) MEDICAMENT FOR TREATING HYPERPHOSPHATEEMIA AND PREPARATION METHOD THEREOF
HK1099689A1 (en) Combination of a heterocyclic compound and an antioxidant and use thereof for the manufacture of a medicament for treating obesity
HUP0300990D0 (en) Synergistic combination for the prophylaxis and treatment of diabetes
HK1205951A1 (en) Use of 7-t-butoxyiminomethylcamptothecin for the prepartion of a medicament for the treatment of uterine neoplasms 7-

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130330